Every 10-Q that Universal Corporation (UVV) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow UVV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UVV filings page.
Universal Corporation reported a weak start to fiscal 2027. For the quarter ended June 30, 2026, sales and other operating revenues were $523.8 million, down 12% from $593.8 million. Operating income fell to $2.3 million from $33.8 million, and net results swung to a $5.0 million loss attributable to Universal, or $(0.20) per diluted share, versus earnings of $0.34 a year earlier. Gross margin contracted to 15.9% from 19.2%.
Tobacco Operations revenue declined 13% to $437.1 million, with operating income down sharply to $3.5 million from $35.7 million on lower volumes, weaker prices, and a less favorable product mix. Ingredients Operations revenue slipped 3% to $86.7 million and moved to a $0.7 million operating loss, pressured by consumer market headwinds, high fixed costs, and inventory write-downs.
Liquidity remains solid: cash and cash equivalents were $173.6 million, net debt was $1.01 billion, and net debt represented 42% of net capitalization, flat versus the prior year. The company had $635 million available under its committed revolving credit facility plus about $279 million of uncommitted lines, with no long-term debt maturities until fiscal 2031. The quarterly dividend was maintained at $0.83 per share, and 51,741 shares were repurchased for $2.7 million.
Universal Corporation reported softer quarterly results as tobacco volumes and margins declined from unusually strong prior-year levels. For the quarter ended December 31, 2025, sales fell to $861.3 million from $937.2 million, and operating income declined to $82.0 million from $104.1 million.
Net income attributable to Universal dropped to $33.2 million from $59.6 million, with diluted EPS down to $1.32 from $2.37, mainly due to lower tobacco sales volumes and higher inventory write-downs, partly offset by lower expenses and favorable currency.
The Tobacco Operations segment remained the earnings driver, generating segment operating income of $84.0 million in the quarter and $185.0 million for the nine months, both below last year on reduced volumes. Ingredients Operations revenue was broadly flat in the quarter, but segment operating income slipped to a small loss on higher fixed costs and market headwinds.
Year-to-date, revenue was $2,209.2 million versus $2,245.0 million, and operating income was $183.4 million versus $190.0 million. The company also put in place a new bank credit agreement with a $780 million five-year revolving facility and two fully funded term loans totaling $620 million, extending maturities and fixing interest on part of the debt through interest rate swaps.
Universal Corporation (UVV) reported fiscal Q2 (quarter ended September 30, 2025) results. Sales and other operating revenues were $754.2 million, up from $710.8 million a year ago. Operating income was $67.6 million versus $68.7 million, while net income attributable to the company rose to $34.2 million from $25.9 million, delivering diluted EPS of $1.36 versus $1.03.
Year to date, revenue reached $1.35 billion versus $1.31 billion, with diluted EPS of $1.70 versus $1.04. Segment sales were $659.4 million for Tobacco Operations and $94.8 million for Ingredients. Segment operating income totaled $65.1 million versus $78.7 million in the prior-year quarter. The effective tax rate was 24.4% for the quarter. Operating cash flow used was $172.4 million, reflecting seasonal inventory build; tobacco inventories were $1.14 billion. The company declared a quarterly dividend of $0.82 per share. As of November 3, 2025, shares outstanding were 24,921,155.
In July 2025, the company received a final favorable ruling in Brazil canceling VAT assessments. A $100 million stock repurchase program remains fully available. During the quarter, the company sold $42.0 million of trade receivables, recognizing a $0.4 million loss.